Lipodystrophy in HIV-1-infected patients

Lancet. 1999 Sep 4;354(9181):867-8. doi: 10.1016/S0140-6736(05)75937-7.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Female
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / adverse effects*
  • HIV Protease Inhibitors / therapeutic use
  • HIV-1*
  • Humans
  • Lipodystrophy / chemically induced*
  • Male

Substances

  • HIV Protease Inhibitors